in
Non verificato

insitro

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza
12/01/2026
Scienza
Tecnica
Sanità
Biotecnologia
Farmaceutica
Salute
Mercato azionario
insitro to Acquire CombinAbleAI to Complete its Full Stack, Modality-Agnostic AI Platform for Drug Discovery and Design
1.00
05/01/2026
Eventi
Industria
Biotecnologia
Tecnica
Sanità
Salute
Farmaceutica
Scienza
Software
insitro to Present at the 44th Annual J.P. Morgan Healthcare Conference
1.00
16/12/2025
Industria
Sanità
Software
Scienza
Farmaceutica
Tecnica
Biotecnologia
Salute
insitro Validates AI-Enabled POSH Platform in Nature Communications, Bridging Critical Gap in Drug Discovery
1.00
03/12/2025
Mercato del lavoro
Industria
Software
Scienza
Sanità
Farmaceutica
Tecnica
Biotecnologia
Tecnologie Varie
Salute
insitro Appoints R&D Veteran Stephen Hitchcock and AI Visionary Vijay Pande as Scientific Advisors
1.00
14/10/2025
Sanità
Software
Scienza
Farmaceutica
Tecnica
Biotecnologia
Salute
Mercato del lavoro
Industria
insitro Extends Research Collaboration with Bristol Myers Squibb Leveraging insitro’s ChemML Discovery Platform
1.00
09/09/2025
Salute
Scienza
Farmaceutica
Biotecnologia
Industria
insitro Partners with Lilly to Build First-in-Kind Machine Learning Models to Advance Small Molecule Drug Discovery
1.00
18/03/2025
Mercato del lavoro
Industria
Salute
Information Technology
Farmaceutica
Tecnica
insitro and UK’s INSIGHT at Moorfields Eye Hospital Announce Collaboration to Expand Research Efforts in Neurodegeneration and Related Conditions
1.00
18/12/2024
Software
Scienza
Associazioni/Professionisti
Farmaceutica
Information Technology
Tecnica
Medicina - Varie
Biotecnologia
Salute
Mercato del lavoro
Industria
insitro Receives $25 Million in Milestone Payments from Bristol Myers Squibb for the Achievement of Discovery Milestones and the Selection of First Novel Genetic Target for ALS
1.00
09/10/2024
Mercato del lavoro
Software
Scienza
Farmaceutica
Tecnica
Biotecnologia
Medicina - Varie
Salute
insitro and Lilly Enter Strategic Agreements to Advance Novel Treatments for Metabolic Diseases
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0